Mar Meijón

MD
Hospital Universitario Ramón y Cajal, Madrid, Spain

Presentation(s):

• OC 65.4 - Idarucizumab for Reversal of Dabigatran: Multicenter Real-World Experience

  Tuesday, July 12, 2022
  3:30 PM – 3:45 PM